AR EO PD is clinically and genetically heterogeneous: it is most frequently caused by PRKN, PINK1 and DJ-1 mutations, particularly in patients with a positive family history and/or consanguinity, with phenotypes resembling typical levodopa-responsive EO PD and slow disease progression. The gene discussed is PINK1; the disease is Parkinson disease.